Similar Papers

Paper Title
Journal
Date
Author
Molecular Characterization of Acute Myeloid Leukemia Patients with Normal Karyotype
Aziz Nazha ... Torsten Haferlach
Blood | VOL. 132
Aziz Nazha, et. al.Aziz Nazha ... Torsten Haferlach
29 Nov 2018
Acute myeloid leukemia with KMT2Ar and association with risk of bleeding and early mortality.
Daniel Nguyen ... Naval Guastad Daver
Journal of Clinical Oncology | VOL. 40
Daniel Nguyen, et. al.Daniel Nguyen ... Naval Guastad Daver
01 Jun 2022
Long-term outcome of NPM1 mutated acute myeloid leukemia: A single-institution experience.
Hamid Sayar ... Shaochun Bai
American journal of hematology | VOL. 92
Hamid Sayar, et. al.Hamid Sayar ... Shaochun Bai
07 Dec 2016
Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia: Role of the NPM1 Mutations May Be Different in Different Races.
Yunsuk Choi ... Kyoo-Hyung Lee
Blood | VOL. 114
Yunsuk Choi, et. al.Yunsuk Choi ... Kyoo-Hyung Lee
20 Nov 2009
View more papers

More From: American journal of hematology

Paper Title
Journal
Date
Author
Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World.
Bruno Fattizzo ... Wilma Barcellini
American journal of hematology | VOL. -
Bruno Fattizzo, et. al.Bruno Fattizzo ... Wilma Barcellini
29 Jan 2025
Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.
Michael Hallek
American journal of hematology | VOL. -
Michael HallekMichael Hallek
28 Jan 2025
Prospective Pharmacokinetic Evaluation of Venetoclax in AML Supports Re-Evaluation of Recommended Dose Adjustments With Azole Antifungals.
Jitesh D Kawedia ... Tapan M Kadia
American journal of hematology | VOL. -
Jitesh D Kawedia, et. al.Jitesh D Kawedia ... Tapan M Kadia
28 Jan 2025
TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance.
Ayalew Tefferi ... Paola Guglielmelli
American journal of hematology | VOL. -
Ayalew Tefferi, et. al.Ayalew Tefferi ... Paola Guglielmelli
28 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.